Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
McDonald's
MCD
|
+$816M |
| 2 |
Crown Castle
CCI
|
+$691M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$581M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$467M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$304M |
Top Sells
| 1 |
Nike
NKE
|
+$1.34B |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$1.09B |
| 3 |
Amazon
AMZN
|
+$671M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$463M |
| 5 |
NXP Semiconductors
NXPI
|
+$452M |
Sector Composition
| 1 | Technology | 20.95% |
| 2 | Consumer Discretionary | 17.67% |
| 3 | Healthcare | 13.89% |
| 4 | Communication Services | 13.06% |
| 5 | Financials | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MON
426
DELISTED
Monsanto Co
MON
| $16.5M | 0.02% |
139,705
-156,500
| -53% | -$18.5M |
|
|
TAHO
427
DELISTED
Tahoe Resources Inc
TAHO
| $16.5M | 0.02% |
1,907,735
-1,566,160
| -45% | -$13.5M |
|
|
BOLD
428
DELISTED
Audentes Therapeutics, Inc
BOLD
| $16.2M | 0.02% |
846,273
+546,617
| +182% | +$10.5M |
|
429
Wheaton Precious Metals
WPM
$47.8B
| $15.9M | 0.02% |
797,757
-61,659
| -7% | -$1.23M |
|
|
POT
430
DELISTED
Potash Corp Of Saskatchewan
POT
| $15.6M | 0.02% |
958,788
-75,924
| -7% | -$1.24M |
|
|
MB
431
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $15.6M | 0.02% |
572,058
+15,792
| +3% | +$430K |
|
|
PSDO
432
DELISTED
Presidio, Inc. Common Stock
PSDO
| $15.5M | 0.02% |
1,081,660
+89,901
| +9% | +$1.29M |
|
433
BlackBerry
BB
$2.26B
| $15.5M | 0.02% |
+1,547,353
| New | +$15.5M |
|
|
NUVA
434
DELISTED
NuVasive, Inc.
NUVA
| $15.2M | 0.02% |
198,163
-9,621
| -5% | -$740K |
|
|
PDCE
435
DELISTED
PDC Energy, Inc.
PDCE
| $15.2M | 0.02% |
352,770
-13,774
| -4% | -$594K |
|
|
AVXS
436
DELISTED
AveXis, Inc. Common Stock
AVXS
| $15.2M | 0.02% |
184,668
+882
| +0.5% | +$72.5K |
|
437
Monolithic Power Systems
MPWR
$40.6B
| $15M | 0.02% |
155,950
-2,892
| -2% | -$279K |
|
438
Enbridge
ENB
$105B
| $14.9M | 0.02% |
375,163
-788,508
| -68% | -$31.4M |
|
439
CNX Resources
CNX
$4.14B
| $14.8M | 0.02% |
1,192,476
-92,826
| -7% | -$1.16M |
|
|
AEUA
440
DELISTED
Anadarko Petroleum Corporation
AEUA
| $14.8M | 0.02% |
361,790
-360
| -0.1% | -$14.8K |
|
441
Neurocrine Biosciences
NBIX
$14.1B
| $14.8M | 0.02% |
322,116
-328,256
| -50% | -$15.1M |
|
|
BWP
442
DELISTED
Boardwalk Pipeline Partners
BWP
| $14.8M | 0.02% |
821,559
-3,682
| -0.4% | -$66.3K |
|
|
TPGH.U
443
DELISTED
TPG Pace Holdings Corp. Units, each consisting of one Class A ordinary share, $.0001 par value, and
TPGH.U
| $14.4M | 0.02% |
+1,400,000
| New | +$14.4M |
|
|
ABMD
444
DELISTED
Abiomed Inc
ABMD
| $14.3M | 0.02% |
99,491
-3,858
| -4% | -$553K |
|
445
Coca-Cola
KO
$293B
| $14.2M | 0.02% |
+315,594
| New | +$14.2M |
|
|
MULE
446
DELISTED
MuleSoft, Inc.
MULE
| $14M | 0.01% |
562,923
+20,823
| +4% | +$519K |
|
|
NBLX
447
DELISTED
Noble Midstream Partners LP
NBLX
| $13.8M | 0.01% |
303,960
-104,494
| -26% | -$4.74M |
|
|
BECN
448
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $13.7M | 0.01% |
279,488
+159,210
| +132% | +$7.8M |
|
449
TG Therapeutics
TGTX
$5.04B
| $13.6M | 0.01% |
1,350,881
-25,412
| -2% | -$255K |
|
450
Syndax Pharmaceuticals
SNDX
$1.36B
| $13.3M | 0.01% |
+953,862
| New | +$13.3M |
|